Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study.

Lima VC, Rosen RB, Maia M, Prata TS, Dorairaj S, Farah ME, Sallum J.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5840-5. doi: 10.1167/iovs.09-4695.

PMID:
20505210
2.

Two-wavelength fundus autofluorescence and macular pigment optical density imaging in diabetic macular oedema.

Waldstein SM, Hickey D, Mahmud I, Kiire CA, Charbel Issa P, Chong NV.

Eye (Lond). 2012 Aug;26(8):1078-85. doi: 10.1038/eye.2012.100.

3.

Macular pigment optical density in central serous chorioretinopathy.

Sasamoto Y, Gomi F, Sawa M, Tsujikawa M, Hamasaki T.

Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5219-25. doi: 10.1167/iovs.09-4881.

PMID:
20445108
4.

Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods.

Trieschmann M, Heimes B, Hense HW, Pauleikhoff D.

Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1565-74.

PMID:
16642363
5.

Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.

Helb HM, Charbel Issa P, VAN DER Veen RL, Berendschot TT, Scholl HP, Holz FG.

Retina. 2008 Jun;28(6):808-16. doi: 10.1097/IAE.0b013e31816d81aa.

PMID:
18536596
6.

Macular pigment density at the site of altered fundus autofluorescence.

Rothenbuehler SP, Wolf-Schnurrbusch UE, Wolf S.

Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):499-504. doi: 10.1007/s00417-010-1528-1.

PMID:
20878175
7.

Color matching in diabetes: optical density of the crystalline lens and macular pigments.

Davies NP, Morland AB.

Invest Ophthalmol Vis Sci. 2002 Jan;43(1):281-9.

PMID:
11773043
8.

Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging.

Tanito M, Obana A, Gohto Y, Okazaki S, Gellermann W, Ohira A.

Jpn J Ophthalmol. 2012 Sep;56(5):488-96. doi: 10.1007/s10384-012-0157-0.

PMID:
22699751
9.

Comparison of macular pigment in patients with age-related macular degeneration and healthy control subjects - a study using spectral fundus reflectance.

Kaya S, Weigert G, Pemp B, Sacu S, Werkmeister RM, Dragostinoff N, Garhöfer G, Schmidt-Erfurth U, Schmetterer L.

Acta Ophthalmol. 2012 Aug;90(5):e399-403. doi: 10.1111/j.1755-3768.2012.02423.x.

10.

Spatial profile of macular pigment and its relationship to foveal architecture.

Nolan JM, Stringham JM, Beatty S, Snodderly DM.

Invest Ophthalmol Vis Sci. 2008 May;49(5):2134-42. doi: 10.1167/iovs.07-0933.

PMID:
18436846
12.

The ringlike structure of macular pigment in age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).

Dietzel M, Zeimer M, Heimes B, Pauleikhoff D, Hense HW.

Invest Ophthalmol Vis Sci. 2011 Oct 11;52(11):8016-24. doi: 10.1167/iovs.11-7610.

PMID:
21896850
13.

Macular pigment: quantitative analysis on autofluorescence images.

Trieschmann M, Spital G, Lommatzsch A, van Kuijk E, Fitzke F, Bird AC, Pauleikhoff D.

Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):1006-12.

PMID:
14618343
14.

Comparison of macular pigment in three types of macular telangiectasia.

Sawa M, Gomi F, Ueno C, Suzuki M, Nishida K.

Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):689-96. doi: 10.1007/s00417-012-2088-3.

PMID:
22790309
15.

Determinants of macular pigment optical density and its relation to age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).

Dietzel M, Zeimer M, Heimes B, Claes B, Pauleikhoff D, Hense HW.

Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3452-7. doi: 10.1167/iovs.10-6713.

PMID:
21296816
16.

Light exposure and macular pigment optical density.

Wenzel AJ, Fuld K, Stringham JM.

Invest Ophthalmol Vis Sci. 2003 Jan;44(1):306-9.

PMID:
12506089
17.

Measurement of macular pigment optical density using two different heterochromatic flicker photometers.

Loane E, Stack J, Beatty S, Nolan JM.

Curr Eye Res. 2007 Jun;32(6):555-64.

PMID:
17612971
18.

Effect of cataract in evaluation of macular pigment optical density by autofluorescence spectrometry.

Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K.

Invest Ophthalmol Vis Sci. 2011 Feb 16;52(2):927-32. doi: 10.1167/iovs.10-5664.

PMID:
21071730
19.

Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).

Tsika C, Tsilimbaris MK, Makridaki M, Kontadakis G, Plainis S, Moschandreas J.

Acta Ophthalmol. 2011 Nov;89(7):e573-8. doi: 10.1111/j.1755-3768.2011.02170.x.

20.

The macular pigment optical density spatial profile and increasing age.

Beirne RO.

Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):383-8. doi: 10.1007/s00417-013-2471-8.

PMID:
24081317
Items per page

Supplemental Content

Support Center